Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome

Marwa Zafarullah,Kathleen Angkustsiri,Austin Quach,Seungjun Yeo,Blythe P. Durbin-Johnson,Heather Bowling,Flora Tassone
DOI: https://doi.org/10.1007/s11306-024-02088-0
2024-02-29
Metabolomics
Abstract:The chromosome 22q11.2 deletion syndrome (22q11.2DS) is characterized by a well-defined microdeletion and is associated with a wide range of brain-related phenotypes including schizophrenia spectrum disorders (SCZ), autism spectrum disorders (ASD), anxiety disorders and attention deficit disorders (ADHD). The typically deleted region in 22q11.2DS contains multiple genes which haploinsufficiency has the potential of altering the protein and the metabolic profiles.
endocrinology & metabolism
What problem does this paper attempt to address?